pharma · Systemic Lupus Erythematosus · Lupus Erythematosus, Systemic
Serana Europe
Serono Europe Limited
Serana Europe trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Pessin, DE HQ
2014 Founded
20 Employees
EMA registrant Type
Company details
- Status
- Public
- HQ
- Pessin, DE
- Founded
- 2014
- Employees
- 20
- Programs
- 8
- Drugs
- 8
- Patents
- 0
Serana Europe clinical trials
Registry index of 8 ClinicalTrials.gov studies linked to Serana Europe programs — each row shows trial ID, program name, phase, status, and indication.
Serana Europe trial registry — 8 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Serana Europe.
-
Placebo — Phase 2
Clinical update -
Enpatoran low dose — Phase 2
Clinical update -
Atacicept 75 mg — Phase 2
Clinical update -
Avelumab — Phase 3
Clinical update -
Xevinapant (Debio 1143) — Phase 3
Clinical update -
M5049 — Phase 2
Clinical update -
M9140 — Phase 2
Clinical update -
Tepotinib — Phase 2
Clinical update